Mason & Associates (California)’s BlackRock ESG Capital Allocation Term Trust ECAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.44M Sell
332,204
-10,308
-3% -$154K 0.86% 27
2025
Q4
$5.27M Buy
+342,512
New +$5.49M 0.99% 28

Other funds holding ECAT

Mason & Associates (California)'s ECAT Position: Q1 2026 in Review

Mason & Associates (California) reduced its BlackRock ESG Capital Allocation Term Trust (ECAT) stake by 3% in Q1 2026, selling an estimated $154K and leaving 332,204 shares worth $4.44M. The position accounts for 0.86% of the portfolio, ranked #27.

Mason & Associates (California) first reported a position in ECAT in Q4 2025 and has held it in 2 quarters since. The position peaked at $5.27M in Q4 2025. 84 funds tracked by Wall St. Rank hold ECAT as of Q1 2026.

  • Mason & Associates (California) held 332,204 shares of BlackRock ESG Capital Allocation Term Trust worth $4.44M as of Q1 2026.
  • Mason & Associates (California) sold 10,308 BlackRock ESG Capital Allocation Term Trust shares in Q1 2026, an estimated $154K.
  • BlackRock ESG Capital Allocation Term Trust made up 0.86% of Mason & Associates (California)'s portfolio in Q1 2026, its #27 holding.
  • Mason & Associates (California) first reported a position in BlackRock ESG Capital Allocation Term Trust in Q4 2025 and has held it in 2 quarters since.
  • Mason & Associates (California)'s BlackRock ESG Capital Allocation Term Trust position peaked at $5.27M in Q4 2025.
  • 84 funds tracked by Wall St. Rank held BlackRock ESG Capital Allocation Term Trust as of Q1 2026.

Based on Mason & Associates (California)'s 13F filing for Q1 2026, filed 30 Apr 2026.